Human MUC1/ADMCKD/ADMCKD1 ORF/cDNA clone-Lentivirus plasmid (NM_001018016)
Cat. No.: pGMLP000558
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human MUC1/ADMCKD/ADMCKD1 Lentiviral expression plasmid for MUC1 lentivirus packaging, MUC1 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.
Go to
MUC1/CA15-3/CA15-3 C-terminal/CD227/MUC1/ADMCKD products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
| Catalog ID | pGMLP000558 |
| Gene Name | MUC1 |
| Accession Number | NM_001018016 |
| Gene ID | 4582 |
| Species | Human |
| Product Type | Lentivirus plasmid (overexpression) |
| Insert Length | 795 bp |
| Gene Alias | ADMCKD,ADMCKD1,CA 15-3,CD227,EMA,H23AG,KL-6,MAM6,MCD,MCKD,MCKD1,MUC-1,MUC-1/SEC,MUC-1/X,MUC1/ZD,PEM,PEMT,PUM |
| Fluorescent Reporter | ZsGreen |
| Mammalian Cell Selection | Puromyocin |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | CMV |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGACACCGGGCACCCAGTCTCCTTTCTTCCTGCTGCTGCTCCTCACAGTGCTTACAGCTACCACAGCCCCTAAACCCGCAACAGTTGTTACGGGTTCTGGTCATGCAAGCTCTACCCCAGGTGGAGAAAAGGAGACTTCGGCTACCCAGAGAAGTTCAGTGCCCAGCTCTACTGAGAAGAATGCTTTTAATTCCTCTCTGGAAGATCCCAGCACCGACTACTACCAAGAGCTGCAGAGAGACATTTCTGAAATGTTTTTGCAGATTTATAAACAAGGGGGTTTTCTGGGCCTCTCCAATATTAAGTTCAGGCCAGGATCTGTGGTGGTACAATTGACTCTGGCCTTCCGAGAAGGTACCATCAATGTCCACGACGTGGAGACACAGTTCAATCAGTATAAAACGGAAGCAGCCTCTCGATATAACCTGACGATCTCAGACGTCAGCGTGAGTGATGTGCCATTTCCTTTCTCTGCCCAGTCTGGGGCTGGGGTGCCAGGCTGGGGCATCGCGCTGCTGGTGCTGGTCTGTGTTCTGGTTGCGCTGGCCATTGTCTATCTCATTGCCTTGGCTGTCTGTCAGTGCCGCCGAAAGAACTACGGGCAGCTGGACATCTTTCCAGCCCGGGATACCTACCATCCTATGAGCGAGTACCCCACCTACCACACCCATGGGCGCTATGTGCCCCCTAGCAGTACCGATCGTAGCCCCTATGAGAAGGTTTCTGCAGGTAATGGTGGCAGCAGCCTCTCTTACACAAACCCAGCAGTGGCAGCCACTTCTGCCAACTTGTAG |
| ORF Protein Sequence | MTPGTQSPFFLLLLLTVLTATTAPKPATVVTGSGHASSTPGGEKETSATQRSSVPSSTEKNAFNSSLEDPSTDYYQELQRDISEMFLQIYKQGGFLGLSNIKFRPGSVVVQLTLAFREGTINVHDVETQFNQYKTEAASRYNLTISDVSVSDVPFPFSAQSGAGVPGWGIALLVLVCVLVALAIVYLIALAVCQCRRKNYGQLDIFPARDTYHPMSEYPTYHTHGRYVPPSSTDRSPYEKVSAGNGGSSLSYTNPAVAATSANL |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Target information
| Target ID | GM-T18779 |
| Target Name | MUC1/CA15-3/CA15-3 C-terminal/CD227 |
|
Gene Group Identifier (Target Gene ID in Homo species) |
4582 |
| Gene ID |
100063415 (Equus caballus), 101093832 (Felis catus), 17829 (Mus musculus), 24571 (Rattus norvegicus) 281333 (Bos taurus), 448784 (Canis lupus familiaris), 4582 (Homo sapiens), 717546 (Macaca mulatta) |
| Gene Symbols & Synonyms | MUC1,Muc1,EMA,CD227,Muc-1,mucin,MCD,PEM,PUM,KL-6,MAM6,MCKD,PEMT,H23AG,MCKD1,MUC-1,ADMCKD,ADTKD2,Ca15-3,ADMCKD1,CA 15-3,MUC-1/X,MUC1/ZD,MUC-1/SEC |
| Target Alternative Names | ADMCKD,ADMCKD1,ADTKD2,Breast carcinoma-associated antigen DF3,CA 15-3,CA15-3,CA15-3 C-terminal,CD227,Ca15-3,Cancer antigen 15-3 (CA 15-3),Carcinoma-associated mucin,EMA,Episialin,H23AG,KL-6,Krebs von den Lungen-6 (KL-6),MAM6,MCD,MCKD,MCKD1,MUC-1,MUC-1/SEC,MUC-1/X,MUC1,MUC1/ZD,Muc-1,Muc1,Mucin-1,PEM,PEMT,PUM,Peanut-reactive urinary mucin (PUM),Polymorphic epithelial mucin (PEM),Tumor-associated epithelial membrane antigen (EMA),Tumor-associated mucin,mucin |
| Uniprot Accession |
P15941,Q02496,Q8WML4
Additional SwissProt Accessions: Q02496,Q8WML4,P15941 |
| Uniprot Entry Name | |
| Protein Sub-location | Transmembrane Protein |
| Category | Therapeutics Target, Immuno-oncology Target, INN Index |
| Disease | cancer, Ovary Cancer |
| Disease from KEGG | |
| Gene Ensembl | ENSECAG00000006646, ENSMUSG00000042784, ENSBTAG00000017104, ENSCAFG00845013058, ENSG00000185499 |
| Target Classification | Checkpoint-Immuno Oncology |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


